{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:45:38Z","timestamp":1776746738093,"version":"3.51.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2022JM-471"],"award-info":[{"award-number":["2022JM-471"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019984","name":"Yan'an Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023-SFGG-079"],"award-info":[{"award-number":["2023-SFGG-079"]}],"id":[{"id":"10.13039\/501100019984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiometabolic multimorbidity (CMM) has become an increasingly serious public health problem. Patients with type 2 diabetes mellitus (T2DM) often present with multiple cardiometabolic disorders and carry a significantly higher risk of CMM. Insulin resistance (IR) is the core mechanism of T2DM and atherosclerotic cardiovascular disease. The triglyceride-glucose index (TyG index) can serve as a reliable alternative for evaluating IR. The pericoronary fat attenuation index (FAI) is a non-invasive biomarker of coronary inflammation based on coronary CT angiography. However, the combined associations of the TyG index and FAI with CMM among patients with T2DM remain unknown. Therefore, this study aims to evaluate the TyG index, RCA-FAI, LAD-FAI, and LCX-FAI in relation to CMM among middle-aged and elderly patients with T2DM in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study and enrolled 497 middle-aged and elderly patients (aged \u226545 years) with T2DM who underwent coronary CT angiography for clinical indications. We defined CMM as the concurrent presence of T2DM together with coronary heart disease or stroke. We used a multivariate logistic regression model to analyze the association between the TyG index and the FAI in each coronary segment (including RCA-FAI, LAD-FAI, and LCX-FAI) with CMM. We presented the study results as odds ratios (ORs) with their corresponding 95% confidence intervals (CIs). We employed restricted cubic splines to analyze the nonlinear relationship and used receiver operating characteristic (ROC) curves to assess the discriminatory capacity of each index in identifying CMM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      After fully adjusting for confounding factors, the TyG index (OR\u00a0=\u00a02.07, 95% CI: 1.44-2.99), RCA-FAI (for each increase of 1 unit: OR\u00a0=\u00a01.19, 95% CI: 1.14-1.23), LAD-FAI (OR\u00a0=\u00a01.16, 95% CI: 1.12-1.21), and LCX-FAI (OR\u00a0=\u00a01.11, 95% CI: 1.07-1.15) were all significantly and positively associated with CMM (all\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001).Dosage-response analysis revealed nonlinear associations of the TyG index and LAD-FAI with CMM (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity &amp;lt; 0.05), whereas RCA-FAI and LCX-FAI showed linear relationships. Receiver operating characteristic (ROC) curve analysis was further performed to evaluate the discriminatory performance of each indicator for CMM. Among these indices, adding the RCA-FAI showed the most pronounced improvement, with a C-statistic of 0.900 (95% CI: 0.873\u20130.926,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001), a net reclassification improvement (NRI) of 0.749 (95% CI: 0.585\u20130.913,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001), and an integrated discrimination improvement (IDI) of 0.141 (95% CI: 0.110\u20130.171,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001). In contrast, adding the TyG index did not meaningfully improve the predictive value of the baseline clinical model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study confirms that among middle-aged and elderly Chinese patients with T2DM, both the TyG index and FAI, including RCA-FAI, LAD-FAI, and LCX-FAI, are independently and positively associated with CMM. However, only coronary FAI indices significantly improve the discriminatory capacity for CMM, with RCA-FAI showing the strongest association and incremental predictive value. These findings suggest that FAI could serve as a useful imaging biomarker for identifying CMM status in patients with T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1801280","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:21:59Z","timestamp":1776745319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of pericoronary fat attenuation index and insulin resistance for the risk of cardiometabolic multimorbidity: a cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Linjuan","family":"Li","sequence":"first","affiliation":[{"name":"Department of General Medicine, Yan\u2019an University Affiliated Hospital","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Child Health Care, Northwest Women\u2019s and Children\u2019s Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yan\u2019an University Affiliated Hospital","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Yan\u2019an University Affiliated Hospital","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Yan\u2019an University Affiliated Hospital","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haimei","family":"Du","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Yan\u2019an University Affiliated Hospital","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuanxia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Yan\u2019an University Affiliated Hospital","place":["Yan\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002513","article-title":"Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study","volume":"15","author":"Tran","year":"2018","journal-title":"PloS Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001985","article-title":"Multimorbidity patterns and association with mortality in 0.5 million Chinese adults","volume":"135","author":"Fan","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2022.01.030","article-title":"Patterns of cardiometabolic multimorbidity and the risk of depressive symptoms in a longitudinal cohort of middle-aged and older Chinese","volume":"301","author":"Huang","year":"2022","journal-title":"J Affect Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac744","article-title":"Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry","volume":"44","author":"Dove","year":"2023","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12933-023-01858-9","article-title":"Duration-dependent impact of cardiometabolic diseases and multimorbidity on all-cause and cause-specific mortality: a prospective cohort study of 0.5 million participants","volume":"22","author":"Han","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13098-023-01186-8","article-title":"Association of cardiometabolic multimorbidity and adherence to a healthy lifestyle with incident dementia: a large prospective cohort study","volume":"15","author":"Xiong","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1495","article-title":"Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis","volume":"365","author":"Kivim\u00e4ki","year":"2019","journal-title":"Bmj"},{"key":"B9","doi-asserted-by":"publisher","first-page":"733080108","DOI":"10.1177\/11795514231220780","article-title":"Cardiometabolic risk factors associated with type 2 diabetes mellitus: a mechanistic insight","volume":"16","author":"Chakraborty","year":"2023","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab413","article-title":"Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study","volume":"42","author":"Han","year":"2021","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1416407","article-title":"Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis","volume":"16","author":"Teimouri","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12933-025-02736-2","article-title":"Association of obesity- and insulin resistance-related indices with subclinical carotid atherosclerosis in type 1 diabetes: a cross-sectional study","volume":"24","author":"Yang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1186\/s40001-025-03375-9","article-title":"Combined effect of chronic inflammation and insulin resistance on stroke: a cohort study and mediation analysis","volume":"30","author":"Gao","year":"2025","journal-title":"Eur J Med Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","article-title":"Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis","volume":"23","author":"Nayak","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","article-title":"Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study","volume":"24","author":"Mo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12933-025-02827-0","article-title":"Association between modified triglyceride glucose indices and stroke risk in middle-aged and older Chinese adults: a prospective cohort study","volume":"24","author":"Sun","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12944-024-02412-6","article-title":"The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes","volume":"23","author":"Gounden","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12933-025-02939-7","article-title":"Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study","volume":"24","author":"Ruan","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-025-02761-1","article-title":"Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study","volume":"24","author":"Zhou","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1629984","article-title":"Pericoronary adipose tissue inflammation mediates the atherogenic effects of lipids on multivessel coronary artery disease: a CCTA-based radiomics analysis","volume":"12","author":"Du","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-022-01478-9","article-title":"High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study","volume":"21","author":"Ichikawa","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12933-024-02272-5","article-title":"The predictive value of lesion-specific pericoronary fat attenuation index for major adverse cardiovascular events in patients with type 2 diabetes","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.240242","article-title":"Incremental prognostic value of perivascular fat attenuation index in patients with diabetes with coronary artery disease","volume":"7","author":"Ding","year":"2025","journal-title":"Radiol Cardiothorac Imaging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/dmso.s571891","article-title":"Pericoronary fat attenuation index mediates the link between TyG index and OSA risk in type 2 diabetes","volume":"19","author":"Zhang","year":"2026","journal-title":"Diabetes Metab Syndrome Obes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeac272","article-title":"Assessment of pericoronary adipose tissue attenuation","volume":"24","author":"Tan","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220885","article-title":"Evaluation of pericoronary adipose tissue attenuation on CT","volume":"96","author":"Ma","year":"2023","journal-title":"Br J Radiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1321942X","DOI":"10.2174\/011573403X321942241023112517","article-title":"Comprehensive review of coronary artery anatomy relevant to cardiac surgery","volume":"21","author":"Kesieme","year":"2025","journal-title":"Curr Cardiol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1531099","article-title":"Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics","volume":"11","author":"Wang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12933-024-02387-9","article-title":"The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study","volume":"23","author":"Molavizadeh","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-023-01939-9","article-title":"An innovative model for predicting coronary heart disease using triglyceride-glucose index: a machine learning-based cohort study","volume":"22","author":"Mirjalili","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S408766","article-title":"Predictive effect of triglyceride-glucose index on adverse prognostic events in patients with type 2 diabetes mellitus and ischemic cardiomyopathy","volume":"16","author":"Abuduaini","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-024-02569-5","article-title":"Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1055\/a-1766-0202","article-title":"Triglyceride-glucose index and the risk of stroke: a systematic review and dose-response meta-analysis","volume":"54","author":"Feng","year":"2022","journal-title":"Horm Metab Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02576-0","article-title":"Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity","volume":"24","author":"Zhang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2174\/1570161115666171010115119","article-title":"Insulin resistance the link between T2DM and CVD: basic mechanisms and clinical implications","volume":"17","author":"Abdul-Ghani","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6170","article-title":"A study of the correlation of insulin resistance and leptin with inflammatory factors and vascular endothelial injury in T2DM patients with CHD","volume":"16","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107058","article-title":"Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases","volume":"200","author":"Domingo","year":"2024","journal-title":"Pharmacol Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201709-723OC","article-title":"Adiposity and asthma in a nationwide study of children and adults in the United States","volume":"15","author":"Forno","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad484","article-title":"Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers","volume":"44","author":"Antoniades","year":"2023","journal-title":"Eur Heart J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237212","article-title":"Epicardial and pericoronary adipose tissue, coronary inflammation, and acute coronary syndromes","volume":"12","author":"Napoli","year":"2023","journal-title":"J Clin Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12933-025-02763-z","article-title":"Advances and challenges of targeting epicardial adipose tissue (EAT) and perivascular adipose tissue (PVAT)","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1801280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:22:02Z","timestamp":1776745322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1801280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":43,"alternative-id":["10.3389\/fendo.2026.1801280"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1801280","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1801280"}}